[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Axogen Inc (AXGN)

Axogen Inc (AXGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Axogen, Inc. to Participate in the 24th Annual Morgan Stanley Global Healthcare Conference

ALACHUA, Fla. and TAMPA, Fla., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative...

AXGN : 49.37 (-1.02%)
MS : 211.31 (+0.13%)
Axogen, Inc. to Participate in the 24th Annual Morgan Stanley Global Healthcare Conference

ALACHUA, Fla. and TAMPA, Fla., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral...

AXGN : 49.37 (-1.02%)
AxoGen: Q2 Earnings Snapshot

AxoGen: Q2 Earnings Snapshot

AXGN : 49.37 (-1.02%)
Axogen, Inc. Reports Second Quarter 2026 Financial Results

Axogen, Inc. Reports Second Quarter 2026 Financial Results

AXGN : 49.37 (-1.02%)
Axogen, Inc. Reports Second Quarter 2026 Financial Results

ALACHUA, Fla. and TAMPA, Fla., July 29, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral...

AXGN : 49.37 (-1.02%)
AXGN's Streak of Earnings Victories May Have Set an Impossible Bar for Tomorrow

Barchart Research What to Expect from AXGN Earnings AXGN Generated July 28, 2026 Current Price $41.15 EPS Estimate $$-0.04 Consensus Rating Strong Buy Average Move 16.31% AXGN's Streak of Earnings Victories...

AXGN : 49.37 (-1.02%)
Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes

Nir Naor appointed Chief Financial Officer effective July 23, 2026, bringing more than 20 years of finance and life sciences experience Cory Anderson promoted to Executive Vice President and General Manager,...

AXGN : 49.37 (-1.02%)
STIM : 2.77 (-2.46%)
Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes

Nir Naor appointed Chief Financial Officer effective July 23, 2026, bringing more than 20 years of finance and life sciences experienceCory Anderson...

AXGN : 49.37 (-1.02%)
STIM : 2.77 (-2.46%)
Axogen, Inc. to Report Second Quarter 2026 Financial Results on July 29, 2026

ALACHUA, Fla. and TAMPA, Fla., July 15, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative...

AXGN : 49.37 (-1.02%)
Axogen, Inc. to Report Second Quarter 2026 Financial Results on July 29, 2026

ALACHUA, Fla. and TAMPA, Fla., July 15, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral...

AXGN : 49.37 (-1.02%)
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.